The biggest mistake made in currency cycles is to confuse revenue gain with pure earnings gain. A company may report stronger rupee revenue...

Granules India has secured tentative approval from the USFDA for its generic ADHD medication. This approval is for Amphetamine extended-rel...

Cipla is set to enter India's weight management market, addressing the increasing demand for obesity solutions, while also strengthening it...

Hema CIPEF is selling 37 lakh shares (0.9% of its total equity) at a discounted price of Rs 2,061 per share, 2% below the current market va...

While all pharma companies get classified into one sector they are very different at molecular level. Each company has its own operating ma...

At the higher end of the price band, the company is expected to raise Rs 1,513.6 crore via its initial shale sale. The promoter holds 100 p...

Cipla Executive Vice-Chairperson Samina Vaziralli said with the government returning for a second consecutive five-year term armed with a s...

The acquisition is Eris’s fourth and the largest buyout in the last 18 months. With this, the company will be among the top ten companies i...

ZCL said it is a speciality pharma company focusing on niche therapeutic areas of central nervous system (CNS), anti-retroviral (ARV) and c...

The new branded product portfolio has a strong fit with Lupin’s Kyowa business, as it adds depth and reach to its current CNS (central nerv...

Aurobindo Pharma today said it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Levoflo...

"The research deal is aimed at developing drug that can benefit large population with unmet needs in the pain management area," Jubilant sa...

The company plans to further strengthen its in-licence portfolio and increase its presence in CNS therapeutic and cardio-vascular segments.

Indian units of global drug majors Pfizer and Wyeth have been star performers on Dalal Street, notching up gains of nearly 55% and 60%, res...

Suven Life Sciences has received product patents in India for three new chemical entities 208688, 208714 and 209540 for treatment of disord...

Ahmedabad-based Torrent Pharmaceuticals on Friday said it has launched three new speciality divisions to cater to niche therapeutic areas o...

Suven Life Sciences Ltd has signed an agreement with US-based pharmaceutical firm Eli Lilly and Company to carryout pre-clinical research f...